Literature DB >> 14731394

Coordination of transcription, RNA processing, and surveillance by P-TEFb kinase on heat shock genes.

Zhuoyu Ni1, Brian E Schwartz, Janis Werner, Jose-Ramon Suarez, John T Lis.   

Abstract

Positive transcription elongation factor b (P-TEFb) is a kinase that phosphorylates the carboxyl-terminal domain (CTD) of RNA Polymerase II (Pol II). Here, we show that flavopiridol, a highly specific P-TEFb kinase inhibitor, dramatically reduces the global levels of Ser2--but not Ser5--phosphorylated CTD at actively transcribed loci on Drosophila polytene chromosomes under both normal and heat shocked conditions. Brief treatment of Drosophila cells with flavopiridol leads to a reduction in the accumulation of induced hsp70 and hsp26 RNAs. Surprisingly, the density of transcribing Pol II and Pol II progression through hsp70 in vivo are nearly normal in flavopiridol-treated cells. The major defect in expression is at the level of 3' end processing. A similar but more modest 3' processing defect was also observed for hsp26. We propose that P-TEFb phosphorylation of Pol II CTD coordinates transcription elongation with 3' end processing, and failure to do so leads to rapid RNA degradation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14731394     DOI: 10.1016/s1097-2765(03)00526-4

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  130 in total

1.  Functional interactions of RNA-capping enzyme with factors that positively and negatively regulate promoter escape by RNA polymerase II.

Authors:  Subhrangsu S Mandal; Chun Chu; Tadashi Wada; Hiroshi Handa; Aaron J Shatkin; Danny Reinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-10       Impact factor: 11.205

Review 2.  Multiple links between transcription and splicing.

Authors:  Alberto R Kornblihtt; Manuel de la Mata; Juan Pablo Fededa; Manuel J Munoz; Guadalupe Nogues
Journal:  RNA       Date:  2004-10       Impact factor: 4.942

3.  RNA polymerase II carboxy-terminal domain phosphorylation is required for cotranscriptional pre-mRNA splicing and 3'-end formation.

Authors:  Gregory Bird; Diego A R Zorio; David L Bentley
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

4.  Transcriptional activators enhance polyadenylation of mRNA precursors.

Authors:  Takashi Nagaike; James L Manley
Journal:  RNA Biol       Date:  2011-11-01       Impact factor: 4.652

5.  P-TEFb kinase complex phosphorylates histone H1 to regulate expression of cellular and HIV-1 genes.

Authors:  Siobhan K O'Brien; Hong Cao; Robin Nathans; Akbar Ali; Tariq M Rana
Journal:  J Biol Chem       Date:  2010-06-15       Impact factor: 5.157

6.  Coordination of RNA Polymerase II Pausing and 3' End Processing Factor Recruitment with Alternative Polyadenylation.

Authors:  Becky Fusby; Soojin Kim; Benjamin Erickson; Hyunmin Kim; Martha L Peterson; David L Bentley
Journal:  Mol Cell Biol       Date:  2015-11-02       Impact factor: 4.272

7.  Interaction of Bunyamwera Orthobunyavirus NSs protein with mediator protein MED8: a mechanism for inhibiting the interferon response.

Authors:  Vincent H J Léonard; Alain Kohl; Timothy J Hart; Richard M Elliott
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

8.  Heat Shock Factor 1 Epigenetically Stimulates Glutaminase-1-Dependent mTOR Activation to Promote Colorectal Carcinogenesis.

Authors:  Jiaqiu Li; Ping Song; Tingting Jiang; Dongjun Dai; Hanying Wang; Jie Sun; Liyuan Zhu; Wenxia Xu; Lifeng Feng; Vivian Y Shin; Helen Morrison; Xian Wang; Hongchuan Jin
Journal:  Mol Ther       Date:  2018-04-14       Impact factor: 11.454

9.  Npl3 is an antagonist of mRNA 3' end formation by RNA polymerase II.

Authors:  Miriam E Bucheli; Stephen Buratowski
Journal:  EMBO J       Date:  2005-05-19       Impact factor: 11.598

10.  The positive transcription elongation factor b is an essential cofactor for the activation of transcription by myocyte enhancer factor 2.

Authors:  Masanori Nojima; Yehong Huang; Mudit Tyagi; Hung-Ying Kao; Koh Fujinaga
Journal:  J Mol Biol       Date:  2008-07-16       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.